Logo image of KND

KINDRED HEALTHCARE INC (KND) Stock Price, Quote, News and Overview

NYSE:KND - New York Stock Exchange, Inc. -

9  -0.05 (-0.55%)

After market: 9 0 (0%)

KND Quote, Performance and Key Statistics

KINDRED HEALTHCARE INC

NYSE:KND (6/29/2018, 8:04:04 PM)

After market: 9 0 (0%)

9

-0.05 (-0.55%)

Sector
GICS SectorN/A
GICS IndustryN/A
GICS IndustryGroupN/A
GICS SubIndustryN/A
Statistics
52 Week High11.9
52 Week Low5.5
Market Cap821.34M
Shares91.26M
Float88.52M
Yearly Dividend0.48
Dividend Yield0%
PE26.47
Fwd PE14.06
Earnings (Next)N/A N/A
IPON/A N/A


KND short term performance overview.The bars show the price performance of KND in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -2 -4 -6

KND long term performance overview.The bars show the price performance of KND in the last 1, 2 and 3 years. 1 year 2 years 3 years -5 -10 -15 -20

The current stock price of KND is 9 null. In the past year, price decreased by -22.75%.

KINDRED HEALTHCARE INC / KND Daily stock chart

About KND

Company Profile

Kindred Healthcare, Inc. is a healthcare services company that operates hospitals, nursing centers, and contract rehabilitation services across the United States. Kindred is the largest diversified post-acute healthcare provider in the U.S.

Company Info

KINDRED HEALTHCARE INC

680 South Fourth Street

Louisville KY 40202

CEO: Benjamin A. Breier

Phone: 502-596-7300

KINDRED HEALTHCARE INC / KND FAQ

What is the stock price of KINDRED HEALTHCARE INC today?

The current stock price of KND is 9 null. The price decreased by -0.55% in the last trading session.


What is the ticker symbol for KINDRED HEALTHCARE INC stock?

The exchange symbol of KINDRED HEALTHCARE INC is KND and it is listed on the New York Stock Exchange, Inc. exchange.


On which exchange is KND stock listed?

KND stock is listed on the New York Stock Exchange, Inc. exchange.


What is KINDRED HEALTHCARE INC worth?

KINDRED HEALTHCARE INC (KND) has a market capitalization of 821.34M null. This makes KND a Small Cap stock.


What are the support and resistance levels for KINDRED HEALTHCARE INC (KND) stock?

KINDRED HEALTHCARE INC (KND) has a support level at 9 and a resistance level at 9. Check the full technical report for a detailed analysis of KND support and resistance levels.


Should I buy KINDRED HEALTHCARE INC (KND) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does KINDRED HEALTHCARE INC (KND) stock pay dividends?

KND does not pay a dividend.


What is the Price/Earnings (PE) ratio of KINDRED HEALTHCARE INC (KND)?

The PE ratio for KINDRED HEALTHCARE INC (KND) is 26.47. This is based on the reported non-GAAP earnings per share of 0.34 and the current share price of 9 null. Check the full fundamental report for a full analysis of the valuation metrics for KND.


KND Technical Analysis

ChartMill assigns a technical rating of 3 / 10 to KND. When comparing the yearly performance of all stocks, KND is a bad performer in the overall market: 81.36% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

KND Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to KND. KND scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

KND Financial Highlights

Over the last trailing twelve months KND reported a non-GAAP Earnings per Share(EPS) of 0.34. The EPS decreased by -55.26% compared to the year before.


Industry RankSector Rank
PM (TTM) -11.56%
ROA -13.34%
ROE -213.38%
Debt/Equity 10.04
Chartmill High Growth Momentum
EPS Q2Q%150%
Sales Q2Q%-1.67%
EPS 1Y (TTM)-55.26%
Revenue 1Y (TTM)0.24%

KND Ownership and Analysts


Ownership
Inst Owners0.02%
Ins Owners0.74%
Short Float %N/A
Short RatioN/A
Analysts
AnalystsN/A
Price TargetN/A
EPS Next Y88.24%
Revenue Next YearN/A